MSB 1.60% 95.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-438

  1. 5,274 Posts.
    lightbulb Created with Sketch. 1642
    One would be crazy to short now as MSB hasn't reached 85c, the price that is equiv to pre-fall (dililution taken cate of) when it was only speculative that FDA would be happy. Now we have the ticked that box re pediactroc trial data (no speculation), BLA is just a formality and two FDA approvals have been achieved. So, 85c is inevitable. So, doesn't sound logical to short ... in any case as a LT holder that is not relevant for me. Science is right, technology is right. All a matter of time, and that time is within reach now ... I would say next quarter is the REAL turning point, once BLA all done and dealt with.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.015(1.60%)
Mkt cap ! $1.084B
Open High Low Value Volume
95.0¢ 95.5¢ 94.0¢ $403.2K 424.7K

Buyers (Bids)

No. Vol. Price($)
13 9964 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.5¢ 100639 21
View Market Depth
Last trade - 12.01pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.